P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
about
Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?Mobile elements and viral integrations prompt considerations for bacterial DNA integration as a novel carcinogenHuman polyomavirus and human papillomavirus prevalence and viral load in non-malignant tonsillar tissue and tonsillar carcinoma.p16 Protein and gigaxonin are associated with the ubiquitination of NFκB in cisplatin-induced senescence of cancer cells.Deregulation of SYCP2 predicts early stage human papillomavirus-positive oropharyngeal carcinoma: A prospective whole transcriptome analysisThe role of high-risk human papillomavirus infections in laryngeal squamous cell carcinoma.Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What is New in the 2017 WHO Blue Book for Tumours of the Hypopharynx, Larynx, Trachea and Parapharyngeal Space.Establishment and characterization of a human papillomavirus type 16-positive tonsillar carcinoma xenograft in BALB/c nude mice.Molecular Patterns and Biology of HPV-Associated HNSCC.HPV Integration in Head and Neck Squamous Cell Carcinomas: Cause and Consequence.Mucosal and cutaneous human papillomaviruses in head and neck squamous cell papillomas.Emerging insights into recurrent and metastatic human papillomavirus-related oropharyngeal squamous cell carcinoma.[The 8th edition of the AJCC Cancer Staging Manual : Updates in otorhinolaryngology, head and neck surgery].Oral and oropharyngeal papillomas are not associated with high-risk human papillomavirus infection.[HPV-associated head and neck cancer : mutational signature and genomic aberrations].[HPV infection in oral, pharyngeal and laryngeal papillomas].Association of human papillomavirus type 58 with breast cancer in Shaanxi province of China.Human papillomavirus dysregulates the cellular apparatus controlling the methylation status of H3K27 in different human cancers to consistently alter gene expression regardless of tissue of originSignificance of p16 expression in head and neck cancer patients treated with radiotherapy and cetuximab.Emerging insights into recurrent and metastatic human papillomavirus‐related oropharyngeal squamous cell carcinoma.Methylation of CpG sites in the upstream regulatory region, physical status and mRNA expression of HPV-6 in adult-onset laryngeal papilloma.Coordinated transcription of ANRIL and P16 genes is silenced by P16 DNA methylation.Oral manifestations of human papillomavirus infections
P2860
Q30252081-E1ABE733-91B6-4791-A137-0F7AD20F4EA5Q34053726-AF70EFFC-3AF1-4DE2-B4FD-AEE4142BF1E7Q34544410-2CB6BBA6-599B-426D-9F08-B1F7C3384CBCQ34683406-0E4F8394-A448-4759-90D4-A9A3C610F98AQ35763033-F7F1A4E6-1047-4EE1-B96F-B6E5FAF5382CQ38634596-E1BB297C-F5C0-4F00-AE54-AF6198BA6E72Q38936405-95007CCB-061A-4DB1-BD18-95CF029B44EBQ38944279-40DA56E8-49F0-4A72-B24E-8DCFE7E747BCQ38971530-1C068965-8DB5-4982-A905-C9854D53543AQ38971534-44D49DF5-25F9-4789-92BA-0395CE34BDCDQ39400513-44F505C3-0A3F-45ED-8467-724D6923EC70Q40046181-CAA3B1C2-31E7-4BE1-AA30-AAD4ADD0E3A5Q40130721-21572F5A-D9DE-4DDF-8725-F37A51CD5813Q40150169-B44E049A-BC7A-4F0F-B0A0-9A0F93BAC414Q40934922-9A99509C-2713-4264-9517-993092773670Q40934928-A8221D83-2C7A-449F-9004-D712947B420CQ41487050-FAD2A46E-0E0C-4018-97F4-E1C71AB7EF76Q42700772-57F31B10-C66C-4092-87D1-3A526851C141Q44481582-B2C5CF80-8733-47D0-9901-C3DD4AA7CE15Q46699165-530C99CC-A6F5-49BA-8D7C-94880C8ABEAAQ47097378-37A2C12E-0E6A-478C-B5EA-9FB62FD90448Q52726238-863B605E-44A4-474A-BC07-928AA9370431Q58766185-99C65AB2-0A18-464C-BDEB-5E5FAB311639
P2860
P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
P16(INK4A) immunostaining is a ...... omas and laryngeal dysplasias.
@en
P16(INK4A) immunostaining is a ...... omas and laryngeal dysplasias.
@nl
type
label
P16(INK4A) immunostaining is a ...... omas and laryngeal dysplasias.
@en
P16(INK4A) immunostaining is a ...... omas and laryngeal dysplasias.
@nl
prefLabel
P16(INK4A) immunostaining is a ...... omas and laryngeal dysplasias.
@en
P16(INK4A) immunostaining is a ...... omas and laryngeal dysplasias.
@nl
P2093
P2860
P356
P1476
P16(INK4A) immunostaining is a ...... omas and laryngeal dysplasias.
@en
P2093
Annick Haesevoets
Bernd Kremer
Carine J Peutz-Kootstra
Christian U Huebbers
Ernst-Jan M Speel
Frans C S Ramaekers
Hans P Dienes
Jens P Klussmann
Jeroen J Mooren
Jos M J A A Straetmans
P2860
P304
P356
10.1002/IJC.28534
P577
2013-10-21T00:00:00Z